Fondaparinux Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Fondaparinux Market size is expected to grow at an annual average of 6% during 2021-2027. Fondaparinux (Arixtra) is a synthetic anticoagulant based on the pentasaccharide sequence constituting the minimal antithrombin (AT) binding region of heparin. Similar to low molecular weight heparin, it is an indirect inhibitor of factor Xa, but not thrombin at all. Fondaparinux has a longer half-life than heparin and does not interact with platelets. Both can be advantageous in certain situations. The indications for fondaparinux include deep vein thrombosis, pulmonary embolism, and superficial vein thrombosis. Binding to antithrombin is the same sequence as UFH and LMWH, but it is not classified as a heparin agent because it lacks an extra chain. It is also known not to cause HIT, as seen in UFH and LMWH.

The following segmentation are covered in this report:

By Application

• Orthopedics (Hip or Knee Replacement)
• Cardiovascular
• Abdominal Surgery
• Others

By End User

• Clinics
• Hospitals
• Diagnostic centres
• Ambulatory Surgical Centres
• Home Care Settings

Company Profile

• Aurobindo Pharma Ltd
• Dr. Reddy’s Laboratories Ltd
• Mylan Inc.
• Jiangsu Hengrui Medicine Co. Ltd
• Scinopharm Taiwan Ltd
• Pfizer Inc
• Novartis AG
• Boehringer Ingelheim GmbH
• GlaxoSmithKline plc

Scope of the report

The research study analyses the Fondaparinux Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Fondaparinux Market Report

• What was the Fondaparinux Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Fondaparinux Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.